The Health Foundation argues that the NHS was "in distress" this winter with A&E waiting times reaching a record high.

Amid everything from the COVID-19 pandemic to recent upswells of influenza and RSV, vaccines have become as common a ...

Flu activity continues to ebb nationwide, with rates of influenza-like illness (ILI) dropping further last week, but ...

Several measures can be adopted to avoid and combat the flu. However, it is important to note that viruses, like influenza, frequently change its structure to evade the immune system, resulting in new ...

A new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation and ...

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.

Healthcare workers remain the most trusted sources of information (73%), while trust in the federal government to provide ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Meeting, held April 24–28 in Honolulu, reveals that young children with chronic conditions are more likely to be hospitalized ...

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.